Next Article in Journal
Development of a Magnetic Electrochemical Bar Code Array for Point Mutation Detection in the H5N1 Neuraminidase Gene
Next Article in Special Issue
Structural and Functional Insights into Foamy Viral Integrase
Previous Article in Journal
Cyclophilins as Modulators of Viral Replication
Previous Article in Special Issue
Simian Foamy Virus in Non-Human Primates and Cross-Species Transmission to Humans in Gabon: An Emerging Zoonotic Disease in Central Africa?
Viruses 2013, 5(7), 1702-1718; doi:10.3390/v5071702
Review

Feline Foamy Virus-Based Vectors: Advantages of an Authentic Animal Model

†,‡
,
,
,
,
,
,
, , #
 and *
Received: 1 March 2013; in revised form: 13 June 2013 / Accepted: 25 June 2013 / Published: 12 July 2013
(This article belongs to the Special Issue Recent Progress in Foamy Virus (FV) Research)
View Full-Text   |   Download PDF [355 KB, updated 17 July 2013; original version uploaded 12 July 2013]   |   Browse Figures
Abstract: New-generation retroviral vectors have potential applications in vaccination and gene therapy. Foamy viruses are particularly interesting as vectors, because they are not associated to any disease. Vector research is mainly based on primate foamy viruses (PFV), but cats are an alternative animal model, due to their smaller size and the existence of a cognate feline foamy virus (FFV). The potential of replication-competent (RC) FFV vectors for vaccination and replication-deficient (RD) FFV-based vectors for gene delivery purposes has been studied over the past years. In this review, the key achievements and functional evaluation of the existing vectors from in vitro cell culture systems to out-bred cats will be described. The data presented here demonstrate the broad application spectrum of FFV-based vectors, especially in pathogen-specific prophylactic and therapeutic vaccination using RD vectors in cats and in classical gene delivery. In the cat-based system, FFV-based vectors provide an advantageous platform to evaluate and optimize the applicability, efficacy and safety of foamy virus (FV) vectors, especially the understudied aspect of FV cell and organ tropism.
Keywords: retrovirus vector; foamy virus; vaccine vector; gene therapy vector; animal model; spumaretrovirus; replication-deficient vector; replication-competent vector retrovirus vector; foamy virus; vaccine vector; gene therapy vector; animal model; spumaretrovirus; replication-deficient vector; replication-competent vector
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Export to BibTeX |
EndNote


MDPI and ACS Style

Liu, W.; Lei, J.; Liu, Y.; Lukic, D.S.; Räthe, A.-M.; Bao, Q.; Kehl, T.; Bleiholder, A.; Hechler, T.; Löchelt, M. Feline Foamy Virus-Based Vectors: Advantages of an Authentic Animal Model. Viruses 2013, 5, 1702-1718.

AMA Style

Liu W, Lei J, Liu Y, Lukic DS, Räthe A-M, Bao Q, Kehl T, Bleiholder A, Hechler T, Löchelt M. Feline Foamy Virus-Based Vectors: Advantages of an Authentic Animal Model. Viruses. 2013; 5(7):1702-1718.

Chicago/Turabian Style

Liu, Weibin; Lei, Janet; Liu, Yang; Lukic, Dragana S.; Räthe, Ann-Mareen; Bao, Qiuying; Kehl, Timo; Bleiholder, Anne; Hechler, Torsten; Löchelt, Martin. 2013. "Feline Foamy Virus-Based Vectors: Advantages of an Authentic Animal Model." Viruses 5, no. 7: 1702-1718.


Viruses EISSN 1999-4915 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert